Romeo et al. developed a multivariate model using a set of radiomics features from dynamic contrast-enhanced (DCE) MRI images in a cohort of 248 participants with ER+, HER2− invasive breast cancer [27]. This evidence concerns the gene ERBB2 and invasive breast carcinoma.